CASI Pharmaceuticals Inc (CASI) — Capital Reinvestment Ratio
Latest as of March 2011:
0.01x
CASI Pharmaceuticals Inc (CASI) has a Capital Reinvestment Ratio of 0.01x as of March 2011, meaning it reinvests 0% of its operating cash flow ($462.74K) in capital expenditures ($4.21K). See CASI Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$462.74K
USD
Capital Expenditures
$4.21K
USD
Data as of
Mar 2011
Most recent filing
Annual Capital Reinvestment Ratio for CASI Pharmaceuticals Inc (None–None)
Year-by-year Capital Reinvestment Ratio for CASI Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see market value of CASI Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow